Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1926

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals? ; day:22 ; month:7 ; year:2020 ; pages:1-20
Clinical pharmacokinetics ; (22.7.2020), 1-20

Creator: Bukkems, Vera E.
Colbers, Angela
Marzolini, Catia
Molto, Jose
Burger, David M.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40262-020-00914-x

URN: urn:nbn:de:101:1-2020091818462129109953

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bukkems, Vera E.
Colbers, Angela
Marzolini, Catia
Molto, Jose
Burger, David M.
SpringerLink (Online service)

Other Objects (12)

Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Clinically relevant drug–drug interactions among elderly people with dementia

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Clinically relevant drug–drug interactions among elderly people with dementia

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Clinically relevant drug–drug interactions among elderly people with dementia

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Clinically relevant drug–drug interactions among elderly people with dementia

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Clinically relevant drug–drug interactions among elderly people with dementia

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Clinically relevant drug–drug interactions among elderly people with dementia

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Related objects

Reset password